WRBY (Warby Parker) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 08, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Warby Parker Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Warby Parker's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Warby Parker's Future 3-5Y EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Warby Parker's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Warby Parker's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Warby Parker's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Warby Parker's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Warby Parker (NYSE:WRBY) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Warby Parker Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Warby Parker's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Warby Parker Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Warby Parker Inc (NYSE:WRBY) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

233 Spring Street, 6th Floor East, New York, NY, USA, 10013

Website

https://www.warbyparker.com

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Executives

David Abraham Gilboa	director, officer: Co-Chief Executive Officer	C/O WARBY PARKER INC., 233 SPRING STREET, 6TH FLOOR, NEW YORK NY 10013
Steven Clive Miller	officer: Chief Financial Officer	C/O WARBY PARKER INC., 233 SPRING STREET, 6TH FLOOR, NEW YORK NY 10013
Neil Harris Blumenthal	director, officer: Co-Chief Executive Officer	C/O WARBY PARKER INC., 233 SPRING STREET, 6TH FLOOR, NEW YORK NY 10013
D1 Capital Partners L.p.	10 percent owner	9 WEST 57TH STREET, 36TH FLOOR, NEW YORK NY 10019
Teresa Briggs	director	2225 LAWSON LANE, SANTA CLARA CA 95054
Durable Capital Partners Lp	10 percent owner	4747 BETHESDA AVENUE, SUITE #1002, BETHESDA MD 20814
Ronald A Williams	director
Jeffrey Jacob Raider	director	C/O WARBY PARKER INC., 233 SPRING STREET, 6TH FLOOR, NEW YORK NY 10013
Andrew Hunt	director	C/O ELEPHANT PARTNERS, 11 NEWBURY STREET, 5TH FLOOR, BOSTON MA 02116
Joel E Cutler	director, 10 percent owner	C/O GENERAL CATALYST PARTNERS, 20 UNIVERSITY ROAD, SUITE 450, CAMBRIDGE MA 02138
Youngme E Moon	director	75 NETWORK DRIVE, BURLINGTON MA 01803
Daniel S. Sundheim	10 percent owner	C/O D1 CAPITAL PARTNERS L.P., 9 WEST 57TH STREET, 36TH FLOOR, NEW YORK NY 10019
General Catalyst Group V Lp	10 percent owner	c/o General Catalyst Group Management LL, 20 University Road Ste 450, Cambridge MA 02138
Gabrielle Sulzberger	director	450 LEXINGTON AVENUE, FLOOR 13, NEW YORK NY 10017
General Catalyst Group Management Holdings, L.p.	10 percent owner	20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138